Atlas Trials

Selective Transvenous Chemoembolization of Primary Pancreatic Tumors

Clinical trial NCT03865563 · WITHDRAWN

Trial details

NCT number
NCT03865563
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Adenocarcinoma
Start date
2019-07-01
Primary completion
2021-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.